Pharmacotherapeutic group
Agents for treatment of biliary disorders. Preparations with bile acids. Ursodeoxycholic acid.

Therapeutic indications
- For dissolution of radiolucent cholesterol gallstones less than 10 mm in diameter in patients with functioning gallbladder;
- cholesterol imbibition of gallbladder;
- bile reflux gastritis;
- expectant treatment of primary biliary cirrhosis (PBC);
- chronic hepatitis and liver cirrhosis associated with cholestatic syndrome (as a part of complex therapy).

URSOLISIN 300 mg
Registration status: UA/8078/01/02; expiry date: 31.03.2013
Dosage: 300 mg
Packaging: caps N20
Shelf-life: 3 years

URSOLISIN 150 mg
Registration status: UA/8078/01/01; expiry date: 31.03.2013
Dosage: 150 mg
Packaging: caps N20
Shelf-life: 3 years

Producer: Magis